Literature DB >> 17708592

Antibody screening database for protein kinetic modeling.

Brett Spurrier1, Frank L Washburn, Samuel Asin, Sundhar Ramalingam, Satoshi Nishizuka.   

Abstract

Knowledge-based proteomic studies rely on the availability of quality antibodies. The increasing number of commercially available antibodies covers a wide range of protein networks; however, performance of each antibody can vary, depending on what type of cells, treatments, and time points are studied. Here, we describe an antibody database in which we screened 279 antibodies against multiple cell lysates after various treatments and from different time points. We applied these quality-confirmed antibodies on protein arrays, showing their utility for protein kinetic modeling.

Mesh:

Substances:

Year:  2007        PMID: 17708592     DOI: 10.1002/pmic.200700117

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  7 in total

Review 1.  Dissecting protein function and signaling using protein microarrays.

Authors:  Alejandro Wolf-Yadlin; Mark Sevecka; Gavin MacBeath
Journal:  Curr Opin Chem Biol       Date:  2009-08-05       Impact factor: 8.822

2.  Lysate microarrays enable high-throughput, quantitative investigations of cellular signaling.

Authors:  Mark Sevecka; Alejandro Wolf-Yadlin; Gavin MacBeath
Journal:  Mol Cell Proteomics       Date:  2011-02-04       Impact factor: 5.911

3.  Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.

Authors:  Rehan Akbani; Karl-Friedrich Becker; Neil Carragher; Ted Goldstein; Leanne de Koning; Ulrike Korf; Lance Liotta; Gordon B Mills; Satoshi S Nishizuka; Michael Pawlak; Emanuel F Petricoin; Harvey B Pollard; Bryan Serrels; Jingchun Zhu
Journal:  Mol Cell Proteomics       Date:  2014-04-28       Impact factor: 5.911

4.  RNAi-based validation of antibodies for reverse phase protein arrays.

Authors:  Heiko A Mannsperger; Stefan Uhlmann; Christian Schmidt; Stefan Wiemann; Ozgür Sahin; Ulrike Korf
Journal:  Proteome Sci       Date:  2010-12-23       Impact factor: 2.480

Review 5.  Facing current quantification challenges in protein microarrays.

Authors:  Robert Wellhausen; Harald Seitz
Journal:  J Biomed Biotechnol       Date:  2012-04-24

6.  Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology.

Authors:  Donghui Ma; Dror Baruch; Youmin Shu; Kehu Yuan; Zairen Sun; Kaiyan Ma; Toan Hoang; Wei Fu; Li Min; Zhu-Sheng Lan; Fangxun Wang; Lori Mull; Wei-Wu He
Journal:  BMC Biotechnol       Date:  2012-11-21       Impact factor: 2.563

7.  α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15.

Authors:  Kohei Kume; Miyuki Ikeda; Sawako Miura; Kohei Ito; Kei A Sato; Yukimi Ohmori; Fumitaka Endo; Hirokatsu Katagiri; Kaoru Ishida; Chie Ito; Takeshi Iwaya; Satoshi S Nishizuka
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.